Apremilast as therapeutic option in a HIV positive patient with severe psoriasis

Dermatol Ther. 2018 Nov;31(6):e12719. doi: 10.1111/dth.12719. Epub 2018 Oct 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Psoriasis / immunology
  • Remission Induction
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Thalidomide
  • apremilast